Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil and behavioral rehabilitation imaging trial in post-stroke Wernicke's aphasia
2005-004215-30Phase 2Completed
- Sponsor
- Joint Sponsorship: University College London (UCL) & University College London Hospitals (UCLH)
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of donepezil in Wernicke aphasia (WA) and stroke (2 arms), sponsored by Joint Sponsorship: University College London (UCL) & University College London Hospitals (UCLH). Primary endpoint: Language modality mean score from the Comprehensive Aphasia Test. Started Jan 2006; status: completed.
02
Drugs
donepezil
03
Conditions
Wernicke aphasia (WA)stroke
Beyond the preview
Go deeper on 2005-004215-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004215-30.